SNWV · NASDAQ
SANUWAVE Health, Inc.
$4.49 -1.34 (-22.98%)
Company overview
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $38.6M
- Employees
- 46
- Headquarters
- Suwanee, GA
- Website
- sanuwave.com
- CEO
- Morgan C. Frank
- Listed
- September 30, 2009
- P/E
- 3.20
- Dividend yield
- 0.00%
Company financials
- Revenue
- $44.3M
- Gross profit
- $33.5M
- Operating income
- $2.8M
- EBITDA
- $22.4M
- Net income
- $16.1M
- EPS
- $1.76
- Total assets
- $37.1M
- Total debt
- $7.2M
- Gross margin
- 75.68%
- Net margin
- 36.21%
- Earnings yield
- 31.22%
No annual geographic segmentation.
Showing FY 2025
SNWV
1D
NASDAQ
O6.05H6.18L5.74C5.83-0.10 (-1.69%)Vol20.80K
News